|Podcasts|June 24, 2021

Predicting Supply Risk and Disruption

Author(s)Nicholas Saraceno, Senior Editor, Michael Christel

C-suite executive shares knowledge surrounding data security and risk mitigation

Atul Vashishta, founder and CEO of Supply Wisdom, a company that delivers continuous risk intelligence, discusses his story in starting up the business, how he identified early risk indicators for Covid disruption, industry approaches to cybersecurity and plenty more.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Predicting Supply Risk and Disruption

Related Content

Pharma Pulse: UPS's Cold Chain Buildout and AbbVie's $10.9B Immunology Bet

What the USMCA Joint Review Means for Pharma

Pharma Pulse: Drug Pricing Pressure in Europe and the New DSV Air Route

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

Pharma Pulse: PBM Crackdowns and Lilly’s $3.8B Vaccine Spree

Trending on Pharmaceutical Commerce

How China Turned US Trade Compliance Into a Supply Chain Risk

Pharma Pulse: UPS's Cold Chain Buildout and AbbVie's $10.9B Immunology Bet

Roundtable: The State of Hub Services in 2026

What the USMCA Joint Review Means for Pharma

Cate Lockhart On Data Sources and the Future of AI in RWE Evaluation